Veeva Systems Inc. $VEEV Position Lessened by Bank Julius Baer & Co. Ltd Zurich

Bank Julius Baer & Co. Ltd Zurich decreased its stake in Veeva Systems Inc. (NYSE:VEEV) by 7.2% during the 4th quarter, HoldingsChannel reports. The firm owned 70,416 shares of the technology company’s stock after selling 5,489 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Veeva Systems were worth $15,745,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC lifted its stake in Veeva Systems by 196.4% in the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after buying an additional 55 shares during the last quarter. Board of the Pension Protection Fund bought a new position in Veeva Systems in the 4th quarter worth about $27,000. Raiffeisen Bank International AG bought a new stake in shares of Veeva Systems during the third quarter valued at approximately $28,000. Newbridge Financial Services Group Inc. boosted its position in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 100 shares during the period. Finally, Activest Wealth Management increased its position in Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after acquiring an additional 127 shares during the period. 88.20% of the stock is currently owned by institutional investors.

Insider Activity at Veeva Systems

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director directly owned 3,253 shares in the company, valued at $506,296.92. This trade represents a 18.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Veeva Systems Stock Up 0.5%

VEEV opened at $156.50 on Friday. The firm has a market cap of $25.56 billion, a PE ratio of 28.93, a P/E/G ratio of 0.69 and a beta of 0.92. The business has a fifty day simple moving average of $172.05 and a 200-day simple moving average of $209.15. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. During the same period in the prior year, the business posted $1.74 earnings per share. Veeva Systems’s revenue was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, equities research analysts anticipate that Veeva Systems Inc. will post 6.41 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on VEEV shares. Truist Financial reiterated a “buy” rating and set a $262.00 price target (down from $275.00) on shares of Veeva Systems in a research report on Thursday, March 5th. Zacks Research upgraded shares of Veeva Systems from a “hold” rating to a “strong-buy” rating in a report on Wednesday, April 15th. Piper Sandler cut their target price on Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Stifel Nicolaus boosted their price objective on Veeva Systems from $212.00 to $245.00 and gave the stock a “buy” rating in a research note on Thursday, March 5th. Finally, UBS Group lifted their target price on Veeva Systems from $200.00 to $220.00 and gave the stock a “neutral” rating in a report on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $278.70.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva is highlighting broader adoption of Vault CRM and AI capabilities, with Roche and BioMarin among the customers cited, reinforcing demand for its life sciences software platform. Article Title
• Positive Sentiment: The company is showcasing “agentic commercial” AI use cases at its Commercial Summit, with biopharma leaders like Bayer, GSK, Merck, and Novo Nordisk participating, which underscores Veeva’s growing credibility in AI-enabled commercial workflows. Article Title
• Positive Sentiment: Smith+Nephew’s adoption of Veeva Quality Cloud expands Veeva’s medtech footprint and adds another validation point for its quality management products. Article Title
• Positive Sentiment: Analyst commentary has focused on Veeva’s expanding partnerships, Vault CRM adoption, and AI improvements from the Ostro acquisition, suggesting a potential path for further upside if execution continues. Article Title
• Neutral Sentiment: Veeva announced it will report fiscal Q1 2027 results on June 3, which keeps investors focused on upcoming earnings but does not change fundamentals by itself. Article Title
• Neutral Sentiment: Recent market writeups note VEEV has been falling even as the broader market advanced, reflecting investor caution despite the company’s positive business developments. Article Title
• Negative Sentiment: Some coverage also described Veeva shares as “plummeting,” signaling that sentiment has weakened recently and that the stock is still reacting to broader concerns about software valuations and execution. Article Title

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.